Red Flags Detected

  • Warning Letter (new) — FDA issued Warning Letter in January 2026 citing Quality Management System, Medical Device Reporting, and Correction and Removals deficiencies.
NASDAQ: BBNX Beta Bionics, Inc. 10-Q

Beta Bionics receives FDA Warning Letter; quality remediation underway as PBP sales climb

Filed April 21, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 6, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade BBNX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.